These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26824954)

  • 1. Regulatory Mutations Impacting Antibiotic Susceptibility in an Established Staphylococcus aureus Biofilm.
    Atwood DN; Beenken KE; Lantz TL; Meeker DG; Lynn WB; Mills WB; Spencer HJ; Smeltzer MS
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1826-9. PubMed ID: 26824954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo.
    Weiss EC; Zielinska A; Beenken KE; Spencer HJ; Daily SJ; Smeltzer MS
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4096-102. PubMed ID: 19651914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of biofilm formation.
    Weiss EC; Spencer HJ; Daily SJ; Weiss BD; Smeltzer MS
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2475-82. PubMed ID: 19289527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
    Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
    BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates.
    Zielinska AK; Beenken KE; Mrak LN; Spencer HJ; Post GR; Skinner RA; Tackett AJ; Horswill AR; Smeltzer MS
    Mol Microbiol; 2012 Dec; 86(5):1183-96. PubMed ID: 23075270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limiting protease production plays a key role in the pathogenesis of the divergent clinical isolates of
    Rom JS; Beenken KE; Ramirez AM; Walker CM; Echols EJ; Smeltzer MS
    Virulence; 2021 Dec; 12(1):584-600. PubMed ID: 33538230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Staphylococcus aureus regulatory mutations that modulate biofilm formation in the USA300 strain LAC on virulence in a murine bacteremia model.
    Rom JS; Atwood DN; Beenken KE; Meeker DG; Loughran AJ; Spencer HJ; Lantz TL; Smeltzer MS
    Virulence; 2017 Nov; 8(8):1776-1790. PubMed ID: 28910576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on prevalence of biofilm associated genes and primary observation on sasX gene in clinical isolates of coagulase negative staphylococci (CoNS).
    Soumya KR; Mathew S; Sugathan S; Mathew J; Radhakrishnan EK
    APMIS; 2016 Apr; 124(4):319-26. PubMed ID: 26847412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Antibiotics Active against Methicillin-Resistant Staphylococcus aureus Based on Activity in an Established Biofilm.
    Meeker DG; Beenken KE; Mills WB; Loughran AJ; Spencer HJ; Lynn WB; Smeltzer MS
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5688-94. PubMed ID: 27401574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibiotic susceptibility and biofilm production of Staphylococcus aureus isolates recovered from bovine intramammary infections that persisted or not following extended therapies with cephapirin, pirlimycin or ceftiofur.
    Ster C; Lebeau V; Leclerc J; Fugère A; Veh KA; Roy JP; Malouin F
    Vet Res; 2017 Sep; 48(1):56. PubMed ID: 28934980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.
    Jiang JH; Dexter C; Cameron DR; Monk IR; Baines SL; Abbott IJ; Spelman DW; Kostoulias X; Nethercott C; Howden BP; Peleg AY
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB; Saravolatz LD; Husain N
    Int J Antimicrob Agents; 2010 Nov; 36(5):478-80. PubMed ID: 20846830
    [No Abstract]   [Full Text] [Related]  

  • 14. Contributions of sigB and sarA to distinct multiple antimicrobial resistance mechanisms of Staphylococcus aureus.
    Riordan JT; O'Leary JO; Gustafson JE
    Int J Antimicrob Agents; 2006 Jul; 28(1):54-61. PubMed ID: 16777384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.
    Denis O; Deplano A; Nonhoff C; Hallin M; De Ryck R; Vanhoof R; De Mendonça R; Struelens MJ
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2680-5. PubMed ID: 16870758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel SigB(Q225P) mutation in Staphylococcus aureus retains virulence but promotes biofilm formation.
    Liu H; Shang W; Hu Z; Zheng Y; Yuan J; Hu Q; Peng H; Cai X; Tan L; Li S; Zhu J; Li M; Hu X; Zhou R; Rao X; Yang Y
    Emerg Microbes Infect; 2018 Apr; 7(1):72. PubMed ID: 29691368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of regulatory genes associated with biofilm variation in a Staphylococcus aureus strain.
    Kim JH; Kim CH; Hacker J; Ziebuhr W; Lee BK; Cho SH
    J Microbiol Biotechnol; 2008 Jan; 18(1):28-34. PubMed ID: 18239412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human methicillin-sensitive Staphylococcus aureus biofilms: potential associations with antibiotic resistance persistence and surface polysaccharide antigens.
    Babra C; Tiwari J; Costantino P; Sunagar R; Isloor S; Hegde N; Mukkur T
    J Basic Microbiol; 2014 Jul; 54(7):721-8. PubMed ID: 23686411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms.
    Lázaro-Díez M; Remuzgo-Martínez S; Rodríguez-Mirones C; Acosta F; Icardo JM; Martínez-Martínez L; Ramos-Vivas J
    PLoS One; 2016; 11(1):e0147569. PubMed ID: 26800524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic activity between an antimicrobial polyacrylamide and daptomycin versus Staphylococcus aureus biofilm.
    Siala W; Van Bambeke F; Taresco V; Piozzi A; Francolini I
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27154750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.